Kevin R. M. Smith's most recent trade in Inogen Inc was a trade of 28,334 Common Stock done . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 28,334 | 100,108 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 28,334 | 28,333 | - | - | Restricted Stock Unit | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.95 per share. | 01 Dec 2025 | 13,817 | 86,291 (0%) | 0% | 6.9 | 96,028 | Common Stock |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 7.99 per share. | 01 Sep 2025 | 1,500 | 71,774 (0%) | 0% | 8.0 | 11,985 | Common Stock |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 90,036 | 90,036 | - | - | Restricted Stock Unit | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 53,975 | 84,662 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 28,333 | 56,667 | - | - | Restricted Stock Unit | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 28,333 | 44,387 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 28 Feb 2025 | 26,097 | 58,565 (0%) | 0% | 8.3 | 217,388 | Common Stock |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 28 Feb 2025 | 13,700 | 30,687 (0%) | 0% | 8.3 | 114,121 | Common Stock |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 8.56 per share. | 28 Feb 2025 | 11,709 | 70,274 (0%) | 0% | 8.6 | 100,245 | Common Stock |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 8.33 per share. | 28 Feb 2025 | 1,500 | 16,054 (0%) | 0% | 8.3 | 12,495 | Common Stock |